World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
43664
World Ranking
8813
National Ranking
4540

Overview

Mark C. Genovese is an active researcher affiliated with Stanford University in the United States. Their work focuses predominantly on the field of medicine, with a strong emphasis on rheumatology, genetics, pathology and forensic medicine, hematology, and immunology.

The researcher has contributed extensively to the study of rheumatoid arthritis, chronic lymphocytic leukemia, lymphoma diagnosis and treatment, autoimmune and inflammatory disorders, biosimilars and bioanalytical methods, systemic lupus erythematosus, and chronic myeloid leukemia treatments.

Some of their recent publications include:

  • Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study (2020, The Lancet Rheumatology)
  • Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (2020, Arthritis & Rheumatology)
  • Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial (2021, Annals of the Rheumatic Diseases)
  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis (2021, Arthritis Care & Research)
  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis (2021, Arthritis & Rheumatology)

Mark C. Genovese frequently collaborates with other researchers in the field. Frequent co-authors include:

  • Kevin Winthrop
  • Tsutomu Takeuchi
  • Gerd R Burmester
  • R. Besuyen
  • Beatrix Bartók

Their work appears regularly in several leading publication venues, demonstrating a consistent presence in the academic community. These venues include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Arthritis & Rheumatology
  • The Lancet Rheumatology
  • Arthritis Research & Therapy

Best Publications

  • Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy : Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

    Stanley B Cohen;Paul Emery;Maria W Greenwald;Maxime Dougados

  • A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

    Joan M. Bathon;Richard W. Martin;Roy M. Fleischmann;John R. Tesser

  • Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.

    Mark C Genovese;Jean-Claude Becker;Michael Schiff;Michael Luggen

  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Liana Fraenkel;Joan M Bathon;Bryant R England;E William St Clair

  • Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.

    Mark C. Genovese;James D. McKay;Evgeny L. Nasonov;Eduardo F. Mysler

  • Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: The AMBITION study

    Graeme Jones;Anthony Sebba;Jieruo Gu;Mitchell B Lowenstein

  • Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.

    Mark C. Genovese;Joan M. Bathon;Richard W. Martin;Roy M. Fleischmann

  • Autoantigen microarrays for multiplex characterization of autoantibody responses

    William H. Robinson;Carla DiGennaro;Wolfgang Hueber;Brian B. Haab

  • Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.

    Mark C. Genovese;Stanley Cohen;Larry Moreland;Deborah Lium

  • Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

    Edward C. Keystone;Mark C. Genovese;Lars Klareskog;Elizabeth C. Hsia

  • Baricitinib in Patients with Refractory Rheumatoid Arthritis

    Mark C. Genovese;Joel Kremer;Omid Zamani;Charles Ludivico

  • LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis a phase I randomized, double-blind, placebo-controlled, proof-of-concept study

    M. C. Genovese;F. Van den Bosch;S. A. Roberson;S. Bojin

  • Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity.

    Eric J. Kunkel;James J. Campbell;Guttorm Haraldsen;Junliang Pan

  • Rules of chemokine receptor association with T cell polarization in vivo

    Chang H. Kim;Lusijah Rott;Eric J. Kunkel;Mark C. Genovese

  • An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

    Michael E. Weinblatt;Arthur Kavanaugh;Mark C. Genovese;Theresa K. Musser

  • Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

    Joel M. Kremer;Mark C. Genovese;Grant W. Cannon;Jacques R. Caldwell

  • Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs.

    Roy Fleischmann;Maurizio Cutolo;Mark C. Genovese;Eun Bong Lee

  • Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial.

    Joel Kremer;Zhan-Guo Li;Stephen Hall;Roy Fleischmann

  • Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis

    Philip J. Mease;Mark C. Genovese;Maria W. Greenwald;Christopher T. Ritchlin

  • Bonzo/CXCR6 expression defines type 1–polarized T-cell subsets with extralymphoid tissue homing potential

    Chang H. Kim;Eric J. Kunkel;Judie Boisvert;Brent Johnston

Frequent Co-Authors

Roy Fleischmann
Roy Fleischmann The University of Texas Southwestern Medical Center
Michael E. Weinblatt
Michael E. Weinblatt Brigham and Women's Hospital
Edward C. Keystone
Edward C. Keystone University of Toronto
Paul Emery
Paul Emery University of Leeds
Joel M. Kremer
Joel M. Kremer Albany Medical Center Hospital
Alan J. Kivitz
Alan J. Kivitz Altoona Arthritis and Osteoporosis Center
Josef S. Smolen
Josef S. Smolen Medical University of Vienna
Gerd R. Burmester
Gerd R. Burmester Charité - University Medicine Berlin
William H. Robinson
William H. Robinson Stanford University
Kevin L. Winthrop
Kevin L. Winthrop Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options beyond a traditional MD in the USA? Many students are considering related online degrees that open doors to healthcare leadership, pharmacy, nursing, and informatics roles. Completing your degree online allows for greater flexibility while balancing work or family commitments.

A major consideration for students is the cost of mha degree, particularly as tuition rates can vary widely. For those interested in advanced nursing, there are dnp online programs cheap that offer affordable routes to becoming a Doctor of Nursing Practice without the expense of on-campus study.

Aspiring pharmacists can take advantage of quality online pharmacy school programs to earn their credentials while studying remotely. Additionally, students interested in medical coding, data management, or digital health can enroll in rhit programs online to prepare for careers in health information management.

Overall, these online healthcare degrees provide accessible and cost-effective pathways to rewarding medical and healthcare careers in the USA.

Best Scientists Citing Mark C. Genovese

Trending Scientists

Recently Published Articles